1. Articles from biospace.com

  2. 1-24 of 71 1 2 3 »
    1. Foghorn® Therapeutics Appoints Scott Biller, Ph.D., to Board of Directors

      Foghorn® Therapeutics Appoints Scott Biller, Ph.D., to Board of Directors

      CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foghorn® Therapeutics Inc. (Foghorn), a company advancing an entirely new class of medicines targeting diseases with genetically determined dependencies in the chromatin regulatory system, today appointed Scott Biller, Ph.D., to its Board of Directors...

      Read Full Article
    2. Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors

      Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors

      SOUTH SAN FRANCISCO, Calif., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Kezar Life SciencesInc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmune disease and cancer, today announced the appointment of Elizabeth Garner, MD, MPH to its Board of Directors. Dr. Garner is currently the Chief Medical Officer of ObsEva SA...

      Read Full Article
    3. IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors

      IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors

      SOUTH SAN FRANCISCO, Calif., Dec. 18, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the appointment of Wendy L. Yarno as a Director of its Board of Directors...

      Read Full Article
    4. Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors

      Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors

      RADNOR, Pa., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or “Company”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy, depression and other neuropsychiatric disorders, announced today that Elan Ezickson, has joined the Company’s Board of Directors...

      Read Full Article
    5. ChanceLight Behavioral Health, Therapy and Education Names John McLaughlin, Ph.D., to Board of Directors

      ChanceLight Behavioral Health, Therapy and Education Names John McLaughlin, Ph.D., to Board of Directors

      NASHVILLE, Tenn.Sept. 12, 2019 /PRNewswire/ -- ChanceLight Behavioral Health, Therapy and Education, the nation's leading provider of behavioral health, therapy and education solutions for children and young adults, today announced John McLaughlin, Ph.D., has transitioned from ChanceLight Executive Vice President to a member of the Board of Directors...

      Read Full Article
    6. Aeromics, Inc. Appoints Nobel Laureate Peter Agre to Its Board of Directors

      Aeromics, Inc. Appoints Nobel Laureate Peter Agre to Its Board of Directors

      NEW HAVEN, Conn., Sept. 9, 2019 /PRNewswire/ -- Aeromics, Inc. ("Aeromics" or "the Company"), a privately-held, clinical-stage pharmaceutical company developing first-in-class anti-edema therapies, announced today the appointment of Peter Agre, M.D. to its Board of Directors. Additionally, Dr. Agre will serve as Chair of the newly-formed Science and Technology Subcommittee of the Board of Directors...

      Read Full Article
    7. Cricket Health Names Colleen Reitan to Board of Directors and Adam Hameed as Chief Development Officer

      Cricket Health Names Colleen Reitan to Board of Directors and Adam Hameed as Chief Development Officer

      SAN FRANCISCOAug. 26, 2019 /PRNewswire/ -- Cricket Health, a comprehensive kidney care provider with a personalized, evidence-based approach to managing care, today announced new additions to the company's senior leadership team. Former health plan leader Colleen Reitan was appointed to the company's board of directors and veteran health care executive Adam Hameed will be joining Cricket Health as chief development officer...

      Read Full Article
    8. ChartSpan Announces Addition to Board of Directors, Sarath Degala of BIP Capital

      ChartSpan Announces Addition to Board of Directors, Sarath Degala of BIP Capital

      GREENVILLE, S.C.Aug. 26, 2019 /PRNewswire/ -- Chartspan, the largest Chronic Care Management provider in the United States, has announced that Sarath Degala, Senior Vice President of BIP Capital, has been appointed to its new Board of Directors. BIP Capital is the leader of a five investor syndicate group that recently closed a $15 millionSeries A round of venture capital with ChartSpan. ChartSpan plans to use the funds to scale its operations nationally...

      Read Full Article
    9. Cell BT (CBI) Announces Appointment of Joshua Ofman, M.D., MSHS, to Board of Directors

      Cell BT (CBI) Announces Appointment of Joshua Ofman, M.D., MSHS, to Board of Directors

      LOS ANGELES--(BUSINESS WIRE)-- Cell BT, Inc. (CBI), an immuno-therapy company focused on the discovery and development of innovative cancer therapeutics based on next generation CAR-T antibody constructs directed to novel biological targets, today announced that Joshua J. Ofman, M.D., MSHS, has been appointed to the CBI Board of Directors...

      Read Full Article
    10. Emergo Therapeutics Board of Directors Welcomes Jack Bailey, President, GSK Pharmaceuticals US

      Emergo Therapeutics Board of Directors Welcomes Jack Bailey, President, GSK Pharmaceuticals US

      DURHAM, N.C., May 30, 2019 /PRNewswire/ -- Emergo Therapeutics, which continues to accelerate its lead candidate norketotifen through Phase 2 studies, has added another seasoned executive to its Board of Directors. Jack Bailey, President, US Pharmaceuticals at GlaxoSmithKline, joined the Board on May 17, 2019. Moise Khayrallah, PhD, CEO and Chairman of the Board, Meg Powell, PharmD, Co-Founder of Target Pharma Solutions, and Bobby Helmedag, Managing Director, Rex Health Ventures, will continue to serve with Bailey...

      Read Full Article
    11. Eiger BioPharmaceuticals Appoints Biotech Veteran Amit K. Sachdev to Board of Directors

      Eiger BioPharmaceuticals Appoints Biotech Veteran Amit K. Sachdev to Board of Directors

      PALO ALTO, Calif., April 15, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of therapies for serious rare and ultra-rare diseases, announced today the appointment of Amit K. Sachdev, JD to its Board of Directors...

      Read Full Article
    1-24 of 71 1 2 3 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content